- Home
- AVXL vs PLAY Comparison
AVXL vs PLAY Comparison
Compare AVXL & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- PLAY
- Stock Information
- Founded
- AVXL 2004
- PLAY 1982
- Country
- AVXL United States
- PLAY United States
- Employees
- AVXL N/A
- PLAY N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- PLAY Restaurants
- Sector
- AVXL Health Care
- PLAY Consumer Discretionary
- Exchange
- AVXL Nasdaq
- PLAY Nasdaq
- Market Cap
- AVXL 956.7M
- PLAY 887.6M
- IPO Year
- AVXL N/A
- PLAY 1995
- Fundamental
- Price
- AVXL $8.63
- PLAY $17.84
- Analyst Decision
- AVXL Strong Buy
- PLAY Buy
- Analyst Count
- AVXL 3
- PLAY 7
- Target Price
- AVXL $44.00
- PLAY $29.33
- AVG Volume (30 Days)
- AVXL 1.4M
- PLAY 1.3M
- Earning Date
- AVXL 08-12-2025
- PLAY 12-09-2025
- Dividend Yield
- AVXL N/A
- PLAY N/A
- EPS Growth
- AVXL N/A
- PLAY N/A
- EPS
- AVXL N/A
- PLAY 0.26
- Revenue
- AVXL N/A
- PLAY $2,112,500,000.00
- Revenue This Year
- AVXL N/A
- PLAY $2.83
- Revenue Next Year
- AVXL N/A
- PLAY $5.65
- P/E Ratio
- AVXL N/A
- PLAY $67.55
- Revenue Growth
- AVXL N/A
- PLAY N/A
- 52 Week Low
- AVXL $5.22
- PLAY $15.08
- 52 Week High
- AVXL $14.44
- PLAY $43.73
- Technical
- Relative Strength Index (RSI)
- AVXL 41.62
- PLAY 42.83
- Support Level
- AVXL $8.41
- PLAY $17.19
- Resistance Level
- AVXL $9.50
- PLAY $19.18
- Average True Range (ATR)
- AVXL 0.48
- PLAY 0.82
- MACD
- AVXL -0.05
- PLAY 0.18
- Stochastic Oscillator
- AVXL 27.98
- PLAY 37.15
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.